Search research articles
Contact Us
Filters
Showing results (11-20 of 129) with videos related to
Page
of 13
Sort By:
Psychopathology
|
September 16, 2009
Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders
N Dekker, D H Linszen, L De Haan
The Journal of Clinical Psychiatry
|
July 13, 1999
Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders
L de Haan, D H Linszen, R Gorsira
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 22, 2000
Duration of untreated psychosis and the long-term course of schizophrenia
L de Haan, M van Der Gaag, J Wolthaus
Immunology and Cell Biology
|
July 31, 1998
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin
L de Haan, W Verweij, E Agsteribbe, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 16, 2004
Opinions of mothers on the first psychotic episode and the start of treatment of their child
L de Haan, K Welborn, M Krikke, et al.
Drug and Alcohol Dependence
|
August 4, 2015
The relation between risk-taking behavior and alcohol use in young adults is different for men and women
L de Haan, A C G Egberts, E R Heerdink
Plos One
|
March 2, 2017
Residual soil nitrate content and profitability of five cropping systems in northwest Iowa
Robert L De Haan, Matthew A Schuiteman, Ronald J Vos
Plos One
|
November 28, 2012
Reliability and validity of the KIPPPI: an early detection tool for psychosocial problems in toddlers
Ingrid Kruizinga, Wilma Jansen, Carolien L de Haan, et al.
The Biochemical Journal
|
January 15, 1993
Domain organization of penicillin-binding protein 5 from Escherichia coli analysed by C-terminal truncation
M P van der Linden, L de Haan, W Keck
Pharmacopsychiatry
|
November 22, 2007
Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up
L de Haan, T van Amelsvoort, P Dingemans, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 129) with videos related to
Sort By:
Page
of 13
Psychopathology
|
September 16, 2009
Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders
N Dekker, D H Linszen, L De Haan
The Journal of Clinical Psychiatry
|
July 13, 1999
Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders
L de Haan, D H Linszen, R Gorsira
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 22, 2000
Duration of untreated psychosis and the long-term course of schizophrenia
L de Haan, M van Der Gaag, J Wolthaus
Immunology and Cell Biology
|
July 31, 1998
The role of ADP-ribosylation and G(M1)-binding activity in the mucosal immunogenicity and adjuvanticity of the Escherichia coli heat-labile enterotoxin and Vibrio cholerae cholera toxin
L de Haan, W Verweij, E Agsteribbe, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
June 16, 2004
Opinions of mothers on the first psychotic episode and the start of treatment of their child
L de Haan, K Welborn, M Krikke, et al.
Drug and Alcohol Dependence
|
August 4, 2015
The relation between risk-taking behavior and alcohol use in young adults is different for men and women
L de Haan, A C G Egberts, E R Heerdink
Plos One
|
March 2, 2017
Residual soil nitrate content and profitability of five cropping systems in northwest Iowa
Robert L De Haan, Matthew A Schuiteman, Ronald J Vos
Plos One
|
November 28, 2012
Reliability and validity of the KIPPPI: an early detection tool for psychosocial problems in toddlers
Ingrid Kruizinga, Wilma Jansen, Carolien L de Haan, et al.
The Biochemical Journal
|
January 15, 1993
Domain organization of penicillin-binding protein 5 from Escherichia coli analysed by C-terminal truncation
M P van der Linden, L de Haan, W Keck
Pharmacopsychiatry
|
November 22, 2007
Risk factors for medication non-adherence in patients with first episode schizophrenia and related disorders; a prospective five year follow-up
L de Haan, T van Amelsvoort, P Dingemans, et al.
Page
of 13